postmenopausal osteoporosis (n = 10), and renal failure (n = 10) were used to assess the clinical agreement among eight commercially available assay kits for osteocalcin (OC). These kits differ in their assay configurations (six radioimmunoassays, two immunoradiometric assays), standards (five bovine, three human), and antibodies (six polyclonal, two monoclonal For Significantly different from control population (mean = 0, SO = 1) at 8 P < 0.001 #{176} P < 0.01, C P < 0.05. 
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